Investors might not be overly excited about Alexion Pharmaceutical 's (NASDAQ: ALXN) stock performance so far in 2020. But with shares trading at only 10 times expected earnings, Alexion is arguably one of the biggest bargains in all of biotech .
Alexion might not be such a bargain for long if continues delivering strong growth. That's exactly what the drugmaker did in the third quarter. Alexion announced its third-quarter results before the market opened on Thursday. Here's why investors liked what they heard.
Image source: Getty Images.
For further details see:
What's Behind Alexion's Impressive Q3 Results